カテゴリ： MarketLine, アメリカ, 企業調査

Royal Caribbean Cruises Ltd.：戦略・SWOT・企業財務分析

◆英語タイトル：Royal Caribbean Cruises Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8014606
◆発行会社（調査会社）：MarketLine
◆発行日：2017年11月10日
◆ページ数：47
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：輸送・物流
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Royal Caribbean Cruises Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Royal Caribbean Cruises Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Royal Caribbean Cruises Ltd. (RCL) is a global cruise vacation company. The company offers cruise services to all major destinations including Asia, North America, Europe, Australia and South America. Its major brands include Azamara Club Cruises Royal Caribbean International, and, Celebrity Cruises . It also operates TUI Cruises through a joint venture agreement with TUI AG, a tourism and shipping company, and SkySea Cruises through partnership agreement with Ctrip.com International Ltd. The cruise line offers onboard activities, services and amenities including dining, simulated surfing, swimming pools, sun decks, beauty salons, and exercise and spa facilities. It provides in-line skating, basketball courts, rock climbing walls, miniature golf courses, gaming facilities, lounges, bars and cinemas. RCL is headquartered in Miami, Florida, the US.

Scope

- Detailed information on Royal Caribbean Cruises Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Royal Caribbean Cruises Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Royal Caribbean Cruises Ltd. including a breakdown and examination of key business segments
- Intelligence on Royal Caribbean Cruises Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Royal Caribbean Cruises Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Royal Caribbean Cruises Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Royal Caribbean Cruises Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Royal Caribbean Cruises Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Royal Caribbean Cruises Ltd.: Company Overview
Royal Caribbean Cruises Ltd.: Overview and Key Facts
Royal Caribbean Cruises Ltd.: Overview
Royal Caribbean Cruises Ltd.: Key Facts
Royal Caribbean Cruises Ltd.: Key Employees
Royal Caribbean Cruises Ltd.: Key Employee Biographies
Royal Caribbean Cruises Ltd.: Major Products and Services
Royal Caribbean Cruises Ltd.: Company History
Royal Caribbean Cruises Ltd.: Management Statement
Royal Caribbean Cruises Ltd.: Locations and Subsidiaries
Royal Caribbean Cruises Ltd.: Key Competitors
Royal Caribbean Cruises Ltd.: Company Analysis
Royal Caribbean Cruises Ltd.: Business Description
Royal Caribbean Cruises Ltd.: SWOT Analysis
Royal Caribbean Cruises Ltd.: SWOT Overview
Royal Caribbean Cruises Ltd.: Strengths
Royal Caribbean Cruises Ltd.: Weaknesses
Royal Caribbean Cruises Ltd.: Opportunities
Royal Caribbean Cruises Ltd.: Threats
Royal Caribbean Cruises Ltd.: Corporate Financial Deals Activity
Royal Caribbean Cruises Ltd.: Financial Deals Overview
Royal Caribbean Cruises Ltd.: Targets and Partners
Royal Caribbean Cruises Ltd.: Top Deals 2013 – 2017YTD*
Royal Caribbean Cruises Ltd.: Partnership
Royal Caribbean Cruises Ltd.: Divestments
Royal Caribbean Cruises Ltd.: Recent Developments
Royal Caribbean Cruises Ltd.: News and Events Summary
Royal Caribbean Cruises Ltd.: Business Expansion
Royal Caribbean Cruises Ltd.: Contracts
Royal Caribbean Cruises Ltd.: Financial Deals
Royal Caribbean Cruises Ltd.: Financial Performance
Royal Caribbean Cruises Ltd.: Regulatory and Legal Events
Royal Caribbean Cruises Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Royal Caribbean Cruises Ltd.: Key Facts
Table 2: Royal Caribbean Cruises Ltd.: Key Employees
Table 3: Royal Caribbean Cruises Ltd.: Locations and Subsidiaries
Table 4: Royal Caribbean Cruises Ltd.: Key Competitors
Table 5: Royal Caribbean Cruises Ltd.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Royal Caribbean Cruises Ltd.: Targets and Partners
Table 7: Royal Caribbean Cruises Ltd.: Top Deals 2013 - 2017YTD*
Table 8: Royal Caribbean Cruises Ltd.: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 9: Royal Caribbean Cruises Ltd.: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 10: Royal Caribbean Cruises Ltd.: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 11: Royal Caribbean Cruises Ltd.: Divestments by Geography (2013 - YTD*2017)
Table 12: Royal Caribbean Cruises Ltd.: News and Events Summary
Table 13: Royal Caribbean Cruises Ltd.: Business Expansion
Table 14: Royal Caribbean Cruises Ltd.: Contracts
Table 15: Royal Caribbean Cruises Ltd.: Financial Deals
Table 16: Royal Caribbean Cruises Ltd.: Financial Performance
Table 17: Royal Caribbean Cruises Ltd.: Regulatory and Legal Events
Table 18: Royal Caribbean Cruises Ltd.: Strategy and Operations

★海外企業調査レポート[Royal Caribbean Cruises Ltd.：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Emory Healthcare Corporate：製薬・医療：M&Aディール及び事業提携情報
    Summary Emory Healthcare Corporate (Emory Healthcare) is a healthcare service provider. The center offers treatments such as acl injuries, aging, als and related conditions, bleeding disorders, bone and tissue tumors, brain health, cancer conditions, dental implants, dermatology, digestive diseases; …
  • Oil & Gas Development Co Ltd (OGDC)
    Oil & Gas Development Co Ltd (OGDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Synexus Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Synexus Ltd (Synexus), a subsidiary of Synexus Clinical Research Limited, is a site management organisation that offers patient recruitment and trial management services. The company services include feasibility assessment, project management, patient engagement, patient-centric clinical tri …
  • Mace Group Ltd：企業の戦略・SWOT・財務情報
    Mace Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Mace Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • IBIDEN Co Ltd (4062)：企業の財務・戦略的SWOT分析
    IBIDEN Co Ltd (4062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • OyaGen Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary OyaGen Inc (OyaGen) is a biotechnology company that discovers, develops and commercializes novel pharmaceutical therapies. The company offers viral infectivity factor Dimerization Antagonist, Vif Interaction with APOBEC3G, Vif dependent polyubiquitination of APOBEC3G and APOBEC3G activators. …
  • Oando Plc (OANDO)：石油・ガス：M&Aディール及び事業提携情報
    Summary Oando Plc (Oando) is a provider of integrated energy solutions to the oil and gas industry. Through its subsidiaries, the company explores for and produces oil and gas through the acquisition of rights in oil blocks on the Nigerian continental shelf and deep offshore. It has producing, devel …
  • Mitsubishi Tanabe Pharma Corp (4508)：企業の財務・戦略的SWOT分析
    Mitsubishi Tanabe Pharma Corp (4508) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Treet Corporation Ltd (TREET)：企業の財務・戦略的SWOT分析
    Treet Corporation Ltd (TREET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Atmos Energy Corp (ATO)：企業の財務・戦略的SWOT分析
    Atmos Energy Corp (ATO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • curasan AG (CUR)：製薬・医療：M&Aディール及び事業提携情報
    Summary curasan AG (curasan) develops, manufactures and commercializes medical devices in the field of regenerative medicine. The company offers a wide range of synthetic bone substitutes, dental and bone regeneration material products. It offers these products to orthopedic and spinal surgeons, ora …
  • Smiths Group Plc (SMIN)-医療機器分野：企業M&A・提携分析
    Summary Smiths Group plc (Smiths Group) is a technology company. It offers products and services for threat and contraband detection, medical devices, energy, and communications industries through five business divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek …
  • New Brunswick Power Corporation：企業の戦略的SWOT分析
    New Brunswick Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • The New York Times Company：企業の戦略・SWOT・財務情報
    The New York Times Company - Strategy, SWOT and Corporate Finance Report Summary The New York Times Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PromptCare Inc-製薬・医療分野：企業M&A・提携分析
    Summary PromptCare Inc (PromptCare) is a healthcare center that respiratory products and home infusion services. The center provides respiratory services such as clinical support programs, patient-focused technology and testimonials. It provides home infusion therapies for patients of all ages with …
  • Carmell Therapeutics Corp：医療機器：M&Aディール及び事業提携情報
    Summary Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio include adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for total j …
  • Hitachi Chemical Co Ltd (4217)：企業の財務・戦略的SWOT分析
    Hitachi Chemical Co Ltd (4217) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • pSivida Corp (PSDV)：製品パイプライン分析
    Summary pSivida Corp (pSivida) is a specialty pharmaceutical company that offers development of miniaturized, sustained-release drug delivery products and technologies. The company’s products include iluvien, retisert and durasert. Its durasert is an injectable, miniaturized, sustained-release drug …
  • Birlasoft Ltd (BSOFT)：企業の財務・戦略的SWOT分析
    Birlasoft Ltd (BSOFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ushdev International Limited (511736)：企業の財務・戦略的SWOT分析
    Ushdev International Limited (511736) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆